Juan C. Jaen sold $467k of RCUS
President at Arcus Biosciences, Inc.. 21,208 shares at an average of $22.01, traded Dec 16, 2025, filed Dec 18, 2025.
Score components
- +20RolePresident
- +17Trade size$467k at market
- 0Share of holdings soldSold 5.8% of holdings
- +15Cluster7 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001422996-25-000015, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 16, 2025 | SOpen-market sale Common Stock10b5-1 | -11,225 | $21.88 | $246k | 355,995 | Dec 18, 2025 |
| Dec 17, 2025 | SOpen-market sale Common Stock10b5-1 | -9,983 | $22.16 | $221k | 346,012 | Dec 18, 2025 |
Related signals
Other insiders at Arcus Biosciences, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 45Moderate | Arcus Biosciences, Inc. | Terry J Rosen Chief Executive Officer | $1.2M 54,691 shares | -2% | |
| 36Weak | Arcus Biosciences, Inc. | Robert C. Goeltz II Chief Financial Officer | $279k 12,662 shares | -15% | |
| 32Weak | Arcus Biosciences, Inc. | Jennifer Jarrett Chief Operating Officer | $467k 21,208 shares | -10% | |
| 32Weak | Arcus Biosciences, Inc. | Alexander Azoy Chief Accounting Officer | $195k 8,832 shares | -32% | |
| 29Weak | Arcus Biosciences, Inc. | Carolyn C. Tang General Counsel | $318k 14,468 shares | -10% | |
| 27Weak | Arcus Biosciences, Inc. | Richard Markus Chief Medical Officer | $210k 9,546 shares | -13% | |
| 40Moderate | Arcus Biosciences, Inc. | Juan C. Jaen President | $2.1M 82,997 shares | -8% | |
| 2Weak | Arcus Biosciences, Inc. | Alexander Azoy Chief Accounting Officer | $49k 1,900 shares | -6% | |
| 27Weak | Arcus Biosciences, Inc. | Robert C. Goeltz II Chief Financial Officer | $125k 5,000 shares | -5% | |
| 40Moderate | Arcus Biosciences, Inc. | Juan C. Jaen President | $1.0M 50,000 shares | -5% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.